NVCR
Novocure Ltd
NASDAQ: NVCR · HEALTHCARE · MEDICAL DEVICES
$11.93
-1.57% today
Updated 2026-04-29
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.11x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$10 – $20
Volume
1.5M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C4.8
Quality
C2.0
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-0.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$25.07
+110.14%
12-Month target
—
—
Intrinsic (DCF)
$64.09
Margin of safety
+83.62%
1 Strong Buy4 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 83.62% below intrinsic value
Risks
- Altman Z -0.55 — distress zone
- Thin margins at -20.80%
- Negative free cash flow $-22.90M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $537.84M | $509.34M | $605.22M | $655.35M | $655.35M |
| Net income | $-92.53M | $-207.04M | $-168.63M | $-136.23M | $-24.50M |
| EPS | — | — | — | — | $-1.22 |
| Free cash flow | $9.43M | $-100.43M | $-69.22M | $-75.68M | $-22.90M |
| Profit margin | -17.20% | -40.65% | -27.86% | -20.79% | -20.80% |
Peer comparison
Smart narrative
Novocure Ltd trades at $11.93. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -0.55, it sits in the distress. TTM revenue stands at $655.35M. with profit margins at -20.80%. Our DCF model estimates intrinsic value at $64.09.
Frequently asked questions
What is Novocure Ltd's stock price?
Novocure Ltd (NVCR) trades at $11.93.
Is Novocure Ltd overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell). DCF value $64.09.
What is the price target of Novocure Ltd (NVCR)?
The analyst target price is $25.07, representing +110.1% upside from the current price of $11.93.
What is the intrinsic value of Novocure Ltd (NVCR)?
Based on our DCF model, intrinsic value is $64.09, a +83.6% margin of safety versus $11.93.
What is Novocure Ltd's revenue?
TTM revenue is $655.35M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-0.55 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.11x
ROE-38.90%
Beta0.82
50D MA$12.05
200D MA$12.56
Shares out0.12B
Float0.09B
Short ratio—
Avg volume1.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—